{"id":60140,"date":"2022-12-20T04:20:00","date_gmt":"2022-12-20T04:20:00","guid":{"rendered":"https:\/\/elpais.com\/salud-y-bienestar\/2022-12-20\/una-variante-danina-del-cancer-de-mama-desata-la-busqueda-urgente-de-una-cura.html"},"modified":"2022-12-20T04:20:00","modified_gmt":"2022-12-20T04:20:00","slug":"una-variante-danina-del-cancer-de-mama-desata-la-busqueda-urgente-de-una-cura","status":"publish","type":"post","link":"https:\/\/forocilac.org\/en\/una-variante-danina-del-cancer-de-mama-desata-la-busqueda-urgente-de-una-cura\/","title":{"rendered":"Una variante da\u00f1ina del c\u00e1ncer de mama desata la b\u00fasqueda urgente de una cura"},"content":{"rendered":"<p>El c\u00e1ncer de mama es el m\u00e1s com\u00fan entre las mujeres y, solo en Europa, ocasiona casi\u202f<a href=\"https:\/\/ecis.jrc.ec.europa.eu\/pdf\/Breast_cancer_factsheet-Dec_2020.pdf\" >92.000 muertes<\/a> al a\u00f1o. Aunque esta cifra es sin duda elevada, las tasas de supervivencia son cada vez mejores. Los avances en la prevenci\u00f3n, la detecci\u00f3n y el tratamiento han hecho posible que hoy en d\u00eda la\u202f<a href=\"https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/breast-cancer\" >tasa de supervivencia<\/a> sea del 90\u202f%.<\/p>\n<p><a href=\"https:\/\/elpais.com\/salud-y-bienestar\/2022-12-20\/una-variante-danina-del-cancer-de-mama-desata-la-busqueda-urgente-de-una-cura.html\" >Keep reading<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Las posibilidades de hacer frente a c\u00e1ncer de mama triple negativo empiezan a vislumbrarse gracias a f\u00e1rmacos de quimioterapia que estimulan el sistema inmune y a otros que producen una implosi\u00f3n de las c\u00e9lulas tumorales<\/p>","protected":false},"author":1332,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[123],"tags":[],"class_list":{"0":"post-60140","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-portal"},"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/forocilac.org\/en\/wp-json\/wp\/v2\/posts\/60140","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/forocilac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/forocilac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/forocilac.org\/en\/wp-json\/wp\/v2\/users\/1332"}],"replies":[{"embeddable":true,"href":"https:\/\/forocilac.org\/en\/wp-json\/wp\/v2\/comments?post=60140"}],"version-history":[{"count":2,"href":"https:\/\/forocilac.org\/en\/wp-json\/wp\/v2\/posts\/60140\/revisions"}],"predecessor-version":[{"id":60142,"href":"https:\/\/forocilac.org\/en\/wp-json\/wp\/v2\/posts\/60140\/revisions\/60142"}],"wp:attachment":[{"href":"https:\/\/forocilac.org\/en\/wp-json\/wp\/v2\/media?parent=60140"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/forocilac.org\/en\/wp-json\/wp\/v2\/categories?post=60140"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/forocilac.org\/en\/wp-json\/wp\/v2\/tags?post=60140"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}